ESMO20 YO for YO: highlights on immune checkpoint blockade for triple-negative breast cancer

ESMO Open. 2021 Feb;6(1):100017. doi: 10.1016/j.esmoop.2020.100017. Epub 2020 Dec 15.

Authors

K Punie¹, A Matikas²

Affiliations

¹ Department of General Medical Oncology and Multidisciplinary Breast Centre, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium. Electronic address: kevin.punie@uzleuven.be.
² Oncology/Pathology Department, Karolinska Institutet, Stockholm, Sweden; Breast Center, Theme Cancer, Karolinska University Hospital, Stockholm, Sweden.

No abstract available

MeSH terms

Humans
Immune Checkpoint Inhibitors
Immunotherapy
Triple Negative Breast Neoplasms* / drug therapy

Substances

Immune Checkpoint Inhibitors